Skip to content

Evotec SE ADR Price, Chart & Factor Analysis

Free Data & Analytics Access
Evotec SE ADR · E.EVO.NASDAQ · United States
Use symbol E.EVO.NASDAQ in our API & Excel add-in to retrieve this data ↓
1.58
(-0.02%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum -50%
Trend -75%
Bubble Risk LOW
Realised Volatility (20D) 60.67%

Evotec SE ADR Forecast

Evotec SE ADR short-term momentum is negative (up over 1 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term SELL signal. The long-term trend is strongly negative (1 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term SELL signal. Based on 20-day realised volatility of 60.7% a year, a typical one-standard-deviation range is 1.4450–1.7150 over a week, 1.3033–1.8567 over a month and 0.6214–2.5386 over a year. (Signals as of 1 Nov 2026.)

Evotec SE ADR Price Chart

MacroFinance.ai
Market/MacroIndicatorNowChangeRange
Quantitative
Evotec SE ADR
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Evotec SE ADR
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Evotec SE ADR
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Evotec SE ADR, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Evotec SE ADR

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Evotec SE ADR Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Evotec SE ADR; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Evotec SE ADR’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Evotec SE ADR behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Evotec SE ADR (United States)

Evotec SE ADR is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

More on Embark Education Group LImited

Frequently asked questions

What is Evotec SE ADR?
Evotec SE ADR is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Evotec SE ADR price?
The latest close is 1.58 (1 Nov 2026), -0.02% on the day. The price at the top of the page refreshes during the trading day.
Is Evotec SE ADR in an uptrend?
As of 1 Nov 2026, short-term momentum is negative (1 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly negative (1 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Evotec SE ADR?
20-day realised volatility is 60.7% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 17.5% over a month and 8.5% over a week.
What factors affect Evotec SE ADR?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Evotec SE ADR, grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Evotec SE ADR?
58 backtested tactical asset allocation strategies trade Evotec SE ADR through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Evotec SE ADR returns analysed?
The Statistical Distribution of Returns section shows the distribution of Evotec SE ADR daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Evotec SE ADR historical data?
In the Free historical data section of this page: the last 10 years of Evotec SE ADR daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Evotec SE ADR historical data (last 10 years)

Browse or instantly download the last 10 years of Evotec SE ADR daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.EVO.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-201.32
2026-11-191.45
2026-11-181.46
2026-11-171.48
2026-11-161.56
2026-11-131.58
2026-11-121.66
2026-11-111.69
2026-11-101.69
2026-11-091.74
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just " Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is also developingcentral nervous system (CNS) and cardiometabolic diseases; and animal and women health. The company has collaboration agreements with Mass General Brigham and Joslin Diabetes Center focusing on cardiometabolic diseases; BMS antiviral; Novo Nordisk cell therapy; University of Oxford; German Cancer Research Center; University Hospital in Hamburg; University of Toronto, Harvard, and Yale; Johns Hopkins University; Ospedale San Raffaele (OSR); and National University of Singapore. In addition, it has a partnership with LAB282, LAB150, beLAB2122, beLAB1407, LAB eN², Danube Labs, VC Amplitude Ventures, LaB eN2, and 65LAB. Further, the company serves pharma and biotechnology companies, academic institutions, patient advocacy groups, and venture capital. Evotec SE has strategic collaboration with Almirall, S.A. for the development of novel therapeutics for severe skin diseases, including a range of immune-mediated inflammatory conditions. The company collaborate with Odyssey Therapeutics, Inc. to designs and develops AI based discovery platform to discover new treatments in autoimmune and inflammatory diseases. The company was formerly known as Evotec AG and changed its name to Evotec SE in April 2019. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany.